Role of host protein GBF1 in organizing enterovirus replication complexes
宿主蛋白 GBF1 在组织肠道病毒复制复合体中的作用
基本信息
- 批准号:9295959
- 负责人:
- 金额:$ 37.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-06-14 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:Alpha CellAntiviral AgentsAntsAsthmaBiologyBiotinBrefeldin ACarrier ProteinsCell physiologyCellsCellular MembraneChronicClinicalCollaborationsCommon ColdComplexCoxsackie VirusesDataDevelopmentDisease OutbreaksEncephalitisEnsureEnterovirusEnterovirus 68Enterovirus 71FDA approvedFamilyFamily PicornaviridaeFoundationsFrequenciesGBF1 geneGenetic VariationGenomeGolgi ApparatusGuanine Nucleotide Exchange FactorsGuanosine TriphosphateGuanosine Triphosphate PhosphohydrolasesHeartHumanHuman poliovirusIn VitroInsulin-Dependent Diabetes MellitusIntegration Host FactorsInterventionKnowledgeLabelLife Cycle StagesLigaseLipidsLungMacromolecular ComplexesMediatingMedicalMembraneMembrane Protein TrafficMetabolic PathwayMetabolismModelingMolecularMolecular and Cellular BiologyMonomeric GTP-Binding ProteinsMutationMyocarditisMyopathyNeurologicObstructionOrganellesParasitesPathogenicityPathway interactionsPharmaceutical PreparationsPoliomyelitisProcessProteinsPublic HealthRNA VirusesRecruitment ActivityResearchResistanceResistance developmentResolutionRhinovirusRoleSmall RNAStructureSyndromeSystemTechniquesTertiary Protein StructureTherapeuticTranslationsUnited StatesVaccinationVaccinesVertebrate VirusesViralViral ProteinsVirusVirus AssemblyVirus DiseasesVirus Replicationdrug developmentgenetic resourcehuman diseasein vivonovelnovel strategiesnovel therapeutic interventionoverexpressionpathogenpressureprotein functionprotein transportscaffoldtherapeutic targettrafficking
项目摘要
Description of the project. Viruses are the ultimate intracellular parasites. With minimal genetic
resources they are able to reroute cellular metabolic pathways and hijack cellular proteins to promote
their own replication. Thus, understanding the role of specific host factors in the viral life cycle is essential
for the development of novel anti-viral strategies. Enteroviruses are a group of picornaviruses, small
+RNA viruses of vertebrates including humans. Enteroviruses cause clinically and economically
important human diseases, ranging from the common cold to fatal encephalitis and myocarditis. High
genetic diversity and adaptability of these viruses complicates development of comprehensive vaccines
and traditional therapeutics targeting virus-specific proteins. Of all the pathogenic enteroviruses, only
polioviruses can be controlled with vaccines, and no clinically approved anti-enterovirus drugs are
available. Thus, novel approaches are urgently needed to control enteroviruses associated with human
diseases. Picornaviruses replicate their genomes on specialized membrane domains, replication
organelles that feature unique lipid and protein composition and whose development relies on the re-
organization of cellular lipid synthesis and membrane trafficking pathways. This implies that at least some
cellular membrane metabolism components must be indispensable for viral propagation. Indeed,
enteroviruses universally require the host protein GBF1 for their replication. GBF1 is a large multi-domain
protein that functions as a guanine nucleotide exchange factor (GEF) for select small GTPases of the Arf
family. GBF1 is a master coordinator of the early steps of protein transport in the secretory pathway, and
participates in maintaining Golgi structure and function and in lipid droplet metabolism. However, how
GBF1 supports the viral replication cycle remains unknown. Attempts to relate the known cellular
activities of GBF1 such as Arf activation, membrane remodeling and recruitment of cellular proteins to
membranes to GBF1 function in viral replication produced controversial results. GBF1 is known to interact
with numerous cellular proteins and with the enterovirus replication protein 3A, but how viruses use these
interactions to their advantage remains unknown. Herein, we propose a new model in which GBF1 acts
as a molecular scaffold to coordinate the assembly of viral and cellular proteins into operational replication
complexes. For this project, we built a team of a cell biologist with a superior expertise in GBF1 biology
(Sztul), and a virologist with an outstanding background in picornavirus replication (Belov). Together, we
will delineate the step(s) in viral life cycle that require GBF1 and uncover the mechanisms of GBF1 action
in the formation function of replication complexes. The universal reliance of diverse enteroviruses on
GBF1 provides an unprecedented opportunity for the development of broad-spectrum therapeutics
targeting GBF1-controlled processes in infected cells.
项目描述。病毒是细胞内的终极寄生虫。最少的基因
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
George A. Belov其他文献
George A. Belov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('George A. Belov', 18)}}的其他基金
Infection-specific lipid metabolism as a target to control enterovirus infections
感染特异性脂质代谢作为控制肠道病毒感染的目标
- 批准号:
10450249 - 财政年份:2022
- 资助金额:
$ 37.38万 - 项目类别:
Infection-specific lipid metabolism as a target to control enterovirus infections
感染特异性脂质代谢作为控制肠道病毒感染的目标
- 批准号:
10597236 - 财政年份:2022
- 资助金额:
$ 37.38万 - 项目类别:
Refocusing the immune response from structural to conserved non-structural proteins as a novel vaccination approach for inducing broad anti-enterovirus protection
将免疫反应从结构蛋白重新聚焦到保守的非结构蛋白,作为诱导广泛抗肠道病毒保护的新型疫苗接种方法
- 批准号:
10041960 - 财政年份:2020
- 资助金额:
$ 37.38万 - 项目类别:
Refocusing the immune response from structural to conserved non-structural proteins as a novel vaccination approach for inducing broad anti-enterovirus protection
将免疫反应从结构蛋白重新聚焦到保守的非结构蛋白,作为诱导广泛抗肠道病毒保护的新型疫苗接种方法
- 批准号:
10254302 - 财政年份:2020
- 资助金额:
$ 37.38万 - 项目类别:
Role of host protein GBF1 in organizing enterovirus replication complexes
宿主蛋白 GBF1 在组织肠道病毒复制复合体中的作用
- 批准号:
9158557 - 财政年份:2016
- 资助金额:
$ 37.38万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 37.38万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 37.38万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 37.38万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 37.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 37.38万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 37.38万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 37.38万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 37.38万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 37.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 37.38万 - 项目类别:














{{item.name}}会员




